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Striatal dopamine transmission underlies numerous
goal-directed behaviors. Medium spiny neurons
(MSNs) are a major target of dopamine in the stria-
tum. However, as dopamine does not directly evoke
a synaptic event in MSNs, the time course of do-
pamine signaling in these cells remains unclear. To
examine how dopamine release activates D2-recep-
tors on MSNs, G protein activated inwardly rectifying
potassium (GIRK2; Kir 3.2) channels were virally over-
expressed in the striatum, and the resulting outward
currents were used as a sensor of D2-receptor
activation. Electrical and optogenetic stimulation of
dopamine terminals evoked robust D2-receptor
inhibitory postsynaptic currents (IPSCs) in GIRK2-
expressing MSNs that occurred in under a second.
Evoked D2-IPSCs could be driven by repetitive
stimulation and were not occluded by background
dopamine tone. Together, the results indicate that
D2-receptors on MSNs exhibit functional low affinity
and suggest that striatal D2-receptors can encode
both tonic and phasic dopamine signals.
INTRODUCTION
Dopamine transmission in the striatum plays a central role in
multiple motivationally relevant behaviors (Schultz, 2007a). Dys-
functions in dopamine signaling underlie a variety of motor and
psychiatric diseases, including Parkinson’s disease, schizo-
phrenia, and drug addiction (Meisenzahl et al., 2007; Volkow
et al., 2009). Dopamine neurons fire in an asynchronous tonic
pacemaker firing pattern that switches to transient synchronous
bursts following the appearance of unexpected reward or cues
predicting those reward (Bromberg-Martin and Hikosaka,
2009; Grace and Bunney, 1984a, 1984b; Phillips et al., 2003;
Schultz, 2007a; Tobler et al., 2005).
Dopamine transients of varying duration have been identified
using techniques that measure the concentration of extracellular
dopamine in brain slices and awake, behaving animals (Chergui
et al., 1994; Garris et al., 1994; Howe et al., 2013; Phillips et al.,
2003; Schultz, 2007b). Phasic dopamine transients that result
from synchronous burst firing are primarily thought to activate164 Neuron 84, 164–176, October 1, 2014 ª2014 Elsevier Inc.low-affinity striatal D1-receptors, while background tonic dopa-
mine levels arising from pacemaker firing maintain steady-state
activation of high-affinity D2-receptors (Cragg and Rice, 2004;
Grace and Bunney, 1984a; Grace et al., 2007; Keefe et al.,
1993; Richfield et al., 1989; Surmeier et al., 2011). The tonic
stimulation of striatal D2-receptors by basal dopamine levels is
proposed to enable several cognitive and motor functions
(Baik et al., 1995; Berke and Hyman, 2000; Schultz, 2007b). As
aberrant changes in tonic dopamine signaling underlie numerous
psychiatric diseases, blocking D2-receptors is currently the cen-
tral strategy of antipsychotic therapies (Howes and Kapur, 2009;
Seeman et al., 2005).
Despite the importance of D2-receptors in striatal function, the
time course over which dopamine transients activate these re-
ceptors on medium spiny neurons (MSNs) has not been charac-
terized. MSNs are the principal output cell of the striatum (Gerfen
and Surmeier, 2011). In MSNs, the activation of D2-receptors
does not induce a direct change in postsynaptic membrane
potential but instead modulates the activity of multiple conduc-
tances through second-messenger-mediated processes (Ger-
fen and Surmeier, 2011; Kreitzer, 2009; Nicola and Malenka,
1998; Surmeier, 2006; Tepper and Plenz, 2006; Tritsch and Sa-
batini, 2012). The slow kinetics of these intracellular signaling
cascades have limited the temporal resolution over which D2-re-
ceptor signaling can be assessed. It therefore remains unclear to
what extent phasic dopamine transients are encoded by these
receptors.
In the present study, an adeno-associated virus (AAV) was
used to drive the expression of G protein-coupled inwardly recti-
fying potassium channels (GIRK2; Kir3.2) in MSNs to provide a
readout of dopamine D2-receptor-mediated transmission with
improved temporal resolution. Multiple Gi/o-coupled receptors
couple to GIRK channels in other regions to evoke metabotropic
IPSCs (Lu¨scher and Slesinger, 2010). Here we found that
following the overexpression of GIRK channels, efficient
coupling to D2-receptors provided a new rapid sensor for
measuring dopamine D2-receptor activation in MSNs.
RESULTS
GIRK Channels Couple to D2-Receptors in MSNs
when Overexpressed
To drive the expression of GIRK2, we designed an AAV encoding
tdTomato-GIRK2 under the control of the synapsin promoter
(Figure 1A). Three weeks following injection of the vector into
Figure 1. Expression of GIRK2 in MSNs
(A) Schematic of AAV2/9.hSyn.tdTomato.T2A.-
GIRK2.WPRE vector injection into the striatum.
(B) AAV-induced expression of GIRK2 and tdTo-
mato in striatal sections 3 weeks following injec-
tion. Shown are tdTomato fluorescence (left),
GIRK2 immunoreactivity (middle), and colocaliza-
tion (right) panels. No tdTomato fluorescence or
GIRK2 immumoreactivity could be detected
above background levels from the contralateral
uninjected hemisphere (far right, merged). Scale
bar equals 30 mm for all panels.
(C) Current-clamp recording from a GIRK2+ MSN.
Membrane responses to +250, +150, and
150 pA current injections.
(D) No differences were found in the passive
membrane properties between wild-type control
MSNs and GIRK2+ MSNs. Left: resting membrane
potential (RMP); middle: membrane input resis-
tance (Rinput); right: MSN firing rate (number of
action potentials (APs) evoked by 450 pA current
injection, 300 ms). Data median and first and third
quartiles are shown as box plots.
(E) Example trace from a GIRK2+ MSN. Bath
application of the D2-agonist quinpirole (1 mM)
evokes an outward current that is reversed by the
D2-antagonist sulpiride (500 nM).
(F) Summary data illustrating the maximum out-
ward current in response to the iontophoretic
application of dopamine in wild-type control
MSNs, GIRK2+ MSNs, and GIRK2+ MSNs in the
presence of sulpiride (500 nM).
(G) DA-evoked current-voltage relationship. 10mV
voltage steps were given from 50 mV to
130 mV. Inserts depict representative traces (shown in 20 mV increments for clarity) under control conditions and in the presence of dopamine. Subtraction of
the control traces from those in the presence of dopamine reveals a conductance that reverses near the predicted potassium reversal potential (n = 6). *** = p <
0.001 by one-way ANOVA with Tukey-Kramer post hoc test. Error bars indicate ± SEM. Numbers in bar graphs represent number of cells recorded. See also
Figure S1.
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Rapid Striatal D2-Receptor Signalingthe striatum, fluorescence from the tdTomato reporter was
widely seen in the striatum (Figure 1B). To confirm that the viral
vector also drove the expression of GIRK2, we counted
tdTomato+ cells and examined the colocalization of tdTomato
with GIRK2 immunoreactivity (Figure 1B). We found that GIRK2
colocalized with 92%± 1%of tdTomato+ cells (782 cells, 16 sec-
tions from three mice), indicating that the vector efficiently
increased expression of both GIRK2 and tdTomato. As previous
studies have shown that the striatum expresses little endoge-
nous GIRK2 (Karschin et al., 1996; Liao et al., 1996), no GIRK2
immunoreactivity could be observed in control striatal hemi-
spheres from uninjected animals (Figure 1B).
To examinewhether endogenousD2-receptors inMSNswould
couple to overexpressed GIRK2 channels, whole-cell voltage-
clamp recordings (holding potential of 60 mV) were made
from GIRK2+ striatal neurons in acute slices 3 to 4 weeks after
AAV injection. We identified MSNs by their well-defined morpho-
logical and electrophysiological characteristics, including a hy-
perpolarized membrane potential, low input resistance, long
delay to initial spiking, and lack of a hyperpolarization-activated
sag (Figure 1C) (Gerfen and Surmeier, 2011; Kita et al., 1984;
Kreitzer, 2009). MSNs expressing GIRK2 displayed a similar
resting membrane potential (control: 84 ± 1 mV, n = 24;
tdTomato+: 83 ± 1 mV, n = 19, p = 0.5, Student’s unpaired ttest), input resistance (control: 47 ± 3 MU, n = 53; tdTomato+:
45 ± 1 MU, n = 132, p = 0.9, Student’s unpaired t test), and rate
of action potential firing following current injection (control: 10 ±
1 APs, n = 28; tdTomato+: 11 ± 1 APs, n = 22; p = 0.5, Student’s
unpaired t test; 300 ms, 450 pA current injection) to control neu-
rons from the uninjected hemisphere (Figure 1D), indicating that
overexpression of GIRK2 did not affect their basic membrane
characteristics. MSNs comprise 95% of striatal neurons, with
approximately half being ‘‘indirect’’-pathway MSNs that express
D2-dopamine receptors (Albin et al., 1989; Graybiel, 1990; Kawa-
guchi et al., 1995; Kreitzer, 2009; Surmeier, 2006). We found that
the D2-selective agonist quinpirole, applied via a puffer pipette,
evoked an outward current in 8 out of 20 GIRK2+ MSNs tested
(91 ± 14 pA, range: 44 to 152 pA, n = 8), suggesting that a signif-
icant proportion of GIRK2+ MSNs were indirect pathway neurons
that expressed functional D2-receptor-coupled channels. Bath
application of quinpirole also evoked currents that were reversed
by the D2-selective antagonist sulpiride (500 nM) (Figure 1E).
Likewise, in the presence of the D1-receptor antagonist
SCH23390 (1 mM), the iontophoretic application of dopamine
evoked large outward currents in roughly half of GIRK2+ MSNs
tested (12 out of 27 cells examined; average amplitude: 131 ±
24 pA, n = 12), which was blocked by sulpiride (500 nM) (15 ±
3 pA, n = 7, p < 0.01, Student’s unpaired t test) (Figure 1F). TheNeuron 84, 164–176, October 1, 2014 ª2014 Elsevier Inc. 165
Figure 2. Phasic Dopamine Transients Drive
D2-IPSCs
(A) Representative whole-cell recording of a GIRK2+
MSN (top) and a control MSN from the uninjected
hemisphere (bottom). A single electrical stimulation
evokes an IPSC that is blocked by the D2-antagonist
sulpiride (1 mM) (top). No IPSC could be evoked in
MSNsfromuninjectedcontrolhemispheres (bottom).
(B) Latency to peak does not correlate with
amplitude of the D2-IPSC (Pearson’s correlation).
Circles represent IPSCs recorded from individual
GIRK2+ MSNs (n = 130).
(C) Whole-cell recordings made in the presence of
sulpiride (1 mM) were subtracted from recordings
of D2-IPSCs to blank the stimulation artifact and
quantify activation kinetics (n = 20). IPSCs ex-
hibited a lag of 55 ± 3 ms prior to reaching 10% of
the peak amplitude and had rise times (10%–90%)
of 111 ± 6 ms (n = 20).
(D) Representative FSCV trace measuring the
[DA]o from a control striatal brain slice in response
to a single stimulation. Inset shows the cyclic
voltammogram produced by a triangular wave-
form (0.4 V to +1.3 V, 400 V/s).
(E) Summary of the [DA]o evoked (measured by FSCV) following a single stimulation. Slices used were taken from animals 3 weeks following AAV.GIRK2 injection
and wild-type controls.
(F) Simultaneous whole-cell recording of a GIRK2+ MSN (black) and FSCV (orange) scaled to the peak. FSCV waveform artifacts in the electrophysiological trace
were blanked. Arrow indicates time point (165 ms poststimulus) used for quantification in (G).
(G) Summary data showing that the D2-IPSC lags behind the [DA]o (n = 10). Presented as the percent of the peak at the second voltammogram (165 ms) after
stimulation. Error bars indicate ± SEM. ** = p < 0.01 and *** = p < 0.001 by Student’s paired t test. See also Figure S2.
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channel activation, since the current-voltage relationship re-
vealed inward rectification and a reversal potential near the pre-
dicted potassium reversal potential (n = 6) (Figure 1G). No out-
ward current occurred in response to dopamine in control
MSNs from uninjected animals (6 ± 1 pA, n = 15, p < 0.001
versus GIRK2+ MSNs, p > 0.05 versus GIRK2+ MSNs in sulpiride,
one-way ANOVA with Tukey-Kramer post hoc test) (Figure 1F).
Thus, following expression of GIRK2, functional channels were
able to couple to endogenous D2-receptors in MSNs.
GIRK2 subunits can form channels either as homotetramers or
heterotetramers with GIRK1 or GIRK3 subunits (Lesage et al.,
1995; Lu¨scher and Slesinger, 2010). Since GIRK1/GIRK2
(Kir3.1-3.2) heterotetramers mediate the GIRK current in many
types of neurons (Karschin et al., 1996; Kobayashi et al., 1995;
Liao et al., 1996), in a subset of mice we overexpressed both
GIRK1 and GIRK2 subunits in MSNs by coinjection of AAV vec-
tors coding for GIRK1-EGFP and GIRK2-tdTomato. Dopamine-
mediated currents recorded from MSNs putatively expressing
GIRK1/2 (EGFP+/tdTomato+) were indistinguishable from those
expressing only GIRK2 (Figure S1 available online), indicating
that expressing GIRK2 subunits was sufficient to produce func-
tional channels in these cells.
Dopamine Release Evokes a D2-IPSC in MSNs
We next asked how the synaptic release of dopamine activates
D2-receptors in MSNs. Recordings were made in the presence
of NMDA, AMPA, GABAA, GABAB, muscarinic, and D1 receptor
antagonists. A single stimulation in the striatum evoked a robust
outward inhibitory postsynaptic current (IPSC) in GIRK2+ MSNs
that was abolished by the D2-receptor antagonist sulpiride166 Neuron 84, 164–176, October 1, 2014 ª2014 Elsevier Inc.(500 nM) (Figure 2A). As expected, D2-IPSCs recorded in the
presence of the D1-antagonist SCH23390 were observed in
roughly half of all GIRK2+ cells recorded (130 out of 302 cells
tested). Dopamine D2-IPSCs displayed an average maximal
amplitude of 102 ± 5 pA (n = 130), with the largest measuring
270 pA (Figure 2B). D2-IPSCs reversed near the predicted potas-
sium reversal potential, which shifted as expected in the pres-
ence of increased extracellular potassium (additional 2.5 mM)
(Figures S2A and S2B). No D2-IPSCs could be evoked in
MSNs from uninjected hemispheres (0 out of 53 cells tested)
(Figures 2A and S2C).
The rise and fall of the IPSC occurred in less than 1 s (Fig-
ure 2A). D2-IPSCs peaked in 258 ± 5 ms, and the duration,
measured at 20% of the peak, was 541 ± 10 ms (n = 130). The
latency to peak of IPSCs did not correlate with amplitude (n =
130, p = 0.4, Pearson’s correlation) (Figure 2B), suggesting
that the kinetics of the IPSC did not depend on the extent of
GIRK2 expression. To better resolve the activation kinetics of
the IPSC, currents in the presence of sulpiride were subtracted
from a subset of D2-IPSCs to eliminate the stimulation artifact
(Figure 2C). D2-IPSCs activated following a lag of 55 ± 3 ms
(time to 10%, n = 20) and had a rise time (10%–90%) of 111 ±
6 ms (n = 20) (Figure 2C). As previous work in the ventral
tegmental area has shown that only high concentrations of dopa-
mine (10–100 mM) evoke somatodendritic D2-receptor-mediated
GIRK currents with similar kinetics (Courtney and Ford, 2014;
Ford et al., 2009), the rapid activation of synaptic currents in
MSNs suggests that a high concentration of dopamine may acti-
vate the D2-receptors mediating the IPSC.
We next directly examined the release of dopamine using fast-
scan cyclic voltammetry (FSCV) to measure axonal dopamine
Figure 3. Synaptic Activation of MSN D2-
Receptors Is Regulated by Uptake
(A) Representative traces illustrating D2-IPSCs
evoked with a single stimulation followed by out-
ward currents evoked by iontophoretic application
of exogenous dopamine (160 nA, 20-50 ms) under
control conditions (black) and in the presence
of the D2-antagonist sulpiride (500 nM, top
trace, red), the inward-rectifier potassium channel
blocker tertiapin-Q (300 nM, middle trace, orange)
and the voltage-gated sodium channel blocker
TTX (600 nM, bottom trace, orange).
(B) Summary data showing the normalized ampli-
tude of both the D2-IPSC and the current evoked
by DA-iontophoresis in different experiments in the
presence of sulpiride (500 nM), tertiapin Q
(300 nM), Ba2+ (200 mM), low Ca2+ (0 mM added),
and TTX (400 nM).
(C) Representative whole-cell recording under
control conditions and in the presence of the DAT-
inhibitor cocaine (10 mM), illustrating the role of
transporters in regulating the time course of
transmission.
(D) Summary data showing the normalized percent
increase in total charge (area under the curve: pA/
ms) of the IPSC in 1 mM (n = 6, p < 0.05) and 10 mM
(n = 7, p < 0.05) cocaine.
(E) Optogenetic activation of ChR2-expressing dopamine terminals in the striatum evokes a D2-IPSC in GIRK2+ MSNs. Left panel: representative trace showing
that the light-evoked IPSC is blocked by the D2-antagonist sulpiride (500 nM). Flash duration was 2 ms (1.0 mW). Right panel: summary data demonstrating
similar time courses of electrically and optogenetically evoked D2-IPSCs (n = 13, p = 0.9).
(F) Representative FSCV trace showing [DA]o in response to optogenetic stimulation of ChR2-expressing dopamine terminals (2 ms flash). Lower panel: cyclic
voltammogram produced by a triangular waveform (0.4 V to +1.3 V, 400 V/s) following optogenetic stimulation of dopamine terminals. Error bars indicate ± SEM.
* = p < 0.05, ** = p < 0.01, and *** = p < 0.001 by Student’s t test. Numbers in bar graphs represent number of cells recorded. See also Figure S3.
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was inserted into the dorsal striatumof brain slices fromeither un-
injected control or AAV.GIRK2-injected mice and cycled (10 Hz)
from 0.4 V to +1.3 V using a triangular waveform (400 V/s). In
control striatal hemispheres, a single stimulation evoked a rise
in the extracellular concentration of dopamine ([DA]o) (Figure 2D)
(Cragg et al., 1997; Hoffman andGerhardt, 1999;Wightman et al.,
1986). There was no difference in evoked peak [DA]o between
GIRK2-expressing slices (0.9 ± 0.2 mM, n = 16) and uninjected
controls (1.3 ± 0.3 mM, n = 9, p = 0.1, Mann-Whitney test) (Fig-
ure 2E), indicating that striatal expression of GIRK2 does not
affect dopamine release. We confirmed the electrochemical
identity of dopamine by the peak of the oxidation and reduction
current in the cyclic voltammogram (Figure 2D, inset).
To determine how the time course of dopamine release related
to the activation of the D2-IPSC, striatal FSCV recordings were
next performed simultaneouslywithwhole-cell voltage-clamp re-
cordings from GIRK2+ MSNs (Figure 2F). The carbon fiber elec-
trode was placed within 100 mm of the MSN being recorded.
When simultaneously measured, a single stimulation evoked an
increase in [DA]o in the bulk extracellular space of 716 ±
120 nM (n = 10) and a D2-IPSC of 95 ± 24 pA (n = 10) (Figure 2F).
The rise in [DA]o could be detected before the activation of the
D2-IPSC (Figure 2F). Cyclic voltammograms were collected
every 100 ms (10 Hz sampling) and aligned such that the first
measurement occurred 65 ms following the electrical stimulus.
A significant increase in the [DA]o could be detected even at the
time when the first poststimulus voltammogram was measured(234 ± 34 nM, n = 10, p < 0.01, Student’s paired t test, reaching
30% ± 3% of the maximum). As currents in the presence of sul-
piride were not subtracted from D2-IPSCs during these simulta-
neous recordings, the initial rise in the outward current at this time
point was likely affected by the stimulation artifact, as the IPSC
wasonly 5%±4%ofmaximumpeak (8 ± 3pA; n= 10) (Figure 2F).
To avoid complication from the stimulus artifact, the IPSCand the
[DA]o were instead compared at the time of the second voltam-
mogram (165 ms poststimulus). The D2-IPSC continued to lag
behind the rise in the [DA]o such that the D2-IPSC had reached
only 53% ± 8% (n = 10) of the maximum while the [DA]o had
reached 77% ± 3% of the maximum (n = 10, p < 0.01, Student’s
paired t test) (Figures 2F and 2G). This indicates that the time
required for metabotropic D2-receptor/G protein/GIRK signaling
likely limits the rate of activation of the IPSC.
Vesicular Dopamine Release Activates
D2-Receptor-Mediated GIRK Currents
To examine the mechanisms underlying D2-receptor-mediated
synaptic transmission in MSNs, outward currents produced by
evoked release were compared to those produced by the exog-
enous application of dopamine by iontophoresis. MSNs that
displayed outward currents in response to exogenous dopa-
mine also exhibited robust IPSCs (Figure 3A), indicating that
neurons that responded to exogenous dopamine also formed
functional synapses with dopamine terminals. Blockade of D2-
receptors with sulpiride (500 nM, n = 7, p < 0.01, Student’s
paired t test) or GIRK channels with either Ba2+ (200 mM,Neuron 84, 164–176, October 1, 2014 ª2014 Elsevier Inc. 167
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blocker tertiapin-Q (300 nM, n = 5, p < 0.001, Student’s paired
t test) inhibited both the IPSC and the current produced by
iontophoresis (Figures 3A and 3B), confirming that both con-
ductances were the result of D2-receptor activation of GIRK
channels. In contrast, inhibiting action potential firing with tetro-
dotoxin (TTX) (400 nM) or limiting presynaptic calcium entry with
low extracellular calcium ACSF (no calcium added) blocked the
D2-IPSC (n = 4 for both, p < 0.001, Student’s paired t test) but
failed to alter the amplitude of the current produced by ionto-
phoresis (n = 4 for both, p > 0.3, Student’s paired t test) (Figures
3A and 3B).
Reuptake by the dopamine transporter (DAT) regulates the
[DA]o following release (Chen et al., 2006; Jones et al., 1998).
To examine how DAT-mediated uptake limits the extent of D2-
receptor activation during the IPSC, we blocked dopamine reup-
take with the monoamine transport blocker cocaine. Cocaine
(10 mM) increased the amplitude (n = 7, p < 0.001, Student’s
paired t test) and duration (n = 7, p < 0.001, Student’s paired t
test) of D2-IPSCs (Figure 3C). This cocaine-induced increase in
IPSC amplitude was D2-receptor dependent, as it was blocked
by subsequent addition of sulpiride (500 nM) (91% ± 1% inhibi-
tion, n = 8, p < 0.001, Student’s paired t test). Cocaine (1 mM,
10 mM) evoked a dose-dependent increase in the total charge
transfer of IPSCs, measured as area under the curve (1 mM:
227% ± 9%, n = 6, p < 0.05; 10 mM: 362% ± 43%, n = 7, p <
0.01, Student’s paired t test) (Figure 3D). Cocaine also increased
the GIRK current induced by exogenous application of dopa-
mine (Figure S3A) but did not change the overall excitability of
GIRK2+ MSNs as assessed by evoked AP firing (Figures S3B
and S3C). Since the duration of receptor activation could be pro-
longed when reuptake was blocked, the results suggest that
dopamine release evoked by a single stimulation only leads to
the transient activation of D2-receptors.
Since MSNs receive inputs from multiple terminals that would
be activated by electrical stimulation (Kreitzer, 2009; Lovinger,
2010), weconfirmed that theD2-IPSCwas the result of dopamine
release from midbrain dopamine terminals in the striatum. The
light-activated ion channel channelrhodopsin-2 (ChR2) was ex-
pressed in midbrain dopamine neurons by stereotaxic injection
of anAAV coding for double-floxedChR2-EYFP into themidbrain
of tyrosine hydroxylase (TH)-Cre transgenic mice (Figures S3D–
S3G). Wide-field illumination of the striatum with pulses of blue
light (2 ms, 1.0 mW) evoked robust IPSCs in approximately
half of GIRK2+ MSNs examined (Figure 3E). IPSCs were abol-
ished by sulpiride (500 nM), and the kinetics of light-evoked cur-
rents were similar to those evoked by electrical stimulation (elec-
trical: time to peak = 262 ± 15 ms, n = 13; optogenetic: time to
peak=262±15,n=13,p=0.9,Student’spaired t test) (Figure3E).
FSCVwas also used tomeasure [DA]o in response to optogenetic
stimulation of ChR2-expressing dopamine terminals, confirming
that a single wide-field pulse of blue light (2 ms) also produced a
peak in the [DA]o (678 ± 203 nM, n = 9) (Figure 3F).
High Concentrations of Dopamine Are Required to
Saturate Striatal D2-Receptors
Pacemaker dopamine firing provides a background dopamine
tone that is important for numerous striatal-dependent functions168 Neuron 84, 164–176, October 1, 2014 ª2014 Elsevier Inc.(Goto and Grace, 2008; Schultz, 2007b). As D2-receptors can
exist in a high-affinity state (Richfield et al., 1989), the nanomolar
background dopamine tone has been hypothesized to maintain
tonic activation of striatal D2-receptors in vivo (Floresco et al.,
2003; Keefe et al., 1993; Schultz, 2007a; Surmeier et al., 2011).
Given that we found that D2-receptors on MSNs encode phasic
dopamine transients, we next examined how dopamine drives
tonic D2-receptor-mediated GIRK signaling.
As dopamine inputs to the striatum are cut in the brain slice,
bath application of low concentrations of dopamine (1 mM) was
used as an initial attempt to mimic background tone. At 1 mM,
dopamine would be predicted to activate D2-receptors in the
high-affinity state (Richfield et al., 1989). Surprisingly, dopamine
at this concentration neither evoked a measurable outward cur-
rent (baseline: 11 ± 8 pA, n = 7, p = 0.2, Student’s paired t test)
nor altered the amplitude of evoked D2-IPSCs (IPSC amplitude:
94% ± 5% of control, n = 7, p = 0.3, Student’s paired t test) (Fig-
ures 4A–4D). Subsequent application of a higher concentration
(10 mM), however, activated a standing outward GIRK current
(31 ± 8 pA, n = 9, p < 0.01, Student’s paired t test) and also
decreased the amplitude of D2-IPSCs (82% ± 4% of control,
n = 9, p < 0.01, Student’s paired t test) (Figures 4A–4D). Applica-
tion of a saturating concentration of dopamine (100 mM) pro-
duced a large current (79 ± 18 pA, n = 5, p < 0.05, Student’s
paired t test) that now completely occluded the D2-IPSC
(8% ± 3% of control, n = 5, p < 0.001, Student’s paired t test)
(Figures 4A–4D). The inhibition of the IPSC had an IC50 of
36 mM (95% confidence interval = 15 mM to 58 mM), and the
dopamine-mediated standing outward current had an EC50 of
18 mM (95% confidence interval = 9 mM to 26 mM) (Figures 4C
and 4D).
As DAT-mediated uptake removes dopamine from the extra-
cellular space, the effective concentration of dopamine that
reaches the receptor within the slice may be less than the con-
centration in the bath. To increase penetration of dopamine
into the slice, the same experiment was repeated in the presence
of cocaine (10 mM). The concentration-response curve for the in-
hibition of the IPSCwas shifted to the left (IC50 = 9 mM, 95% con-
fidence interval = 5 mM to 12 mM), and dopamine evoked larger
amplitude standing outward currents (100 mM dopamine: 79 ±
8 pA, n = 5; 100 mM dopamine in 10 mM cocaine: 190 ± 35 pA,
n = 7, p < 0.05, Student’s unpaired t test; EC50 = 16 mM, 95%
confidence interval = 7 mM to 24 mM) (Figures 4C and 4D). How-
ever, even in the presence of cocaine to block uptake, micro-
molar concentrations of dopamine were still required to produce
sustained D2-receptor activation of GIRK channels. The results
suggest that GIRK-coupled D2-receptors may preferentially
exist in a low-affinity state.
GIRK Overexpression Does Not Affect the Affinity of
Dopamine for D2-Receptors
We next tested whether the high concentration of dopamine
required to activate D2-receptors was a consequence of GIRK
overexpression. In native GPCR-effector systems, the size of
the effector pool often limits the maximal response (Kenakin,
2013; Ostrom et al., 2001). In order to determine whether the
size of the expanded effector pool affected the affinity of dopa-
mine for the D2-receptor, we limited the expression of GIRK by
Figure 4. High Dopamine Concentrations
Saturate D2-Receptors in MSNs
(A) Representative whole-cell recordings in the
presence of 1 mM (left), 10 mM (middle), and 100 mM
(right) dopamine.
(B) Overlay of the dopamine traces shown in (A)
illustrating that higher concentrations are neces-
sary to significantly occlude the D2-IPSC. IPSCs
have been normalized to control baseline levels.
(C) Concentration-response curve under control
conditions (green) and in the presence of 10 mM
cocaine (purple) showing the decrease in IPSC
amplitude induced by bath application of dopa-
mine (control: IC50 = 36 mM; cocaine: IC50 = 9 mM).
(D) Summary data illustrating the increase in
baseline outward current under control conditions
(green) and in 10 mM cocaine (purple) in the pres-
ence of different concentrations of exogenous
dopamine (control: EC50 = 18 mM; cocaine: EC50 =
16 mM). Error bars indicate ± SEM. * = p < 0.05 and
** = p < 0.01 by one-sample Student’s t test. # = p <
0.05 by Student’s unpaired t test. Numbers in bar
graphs represent number of cells recorded.
Neuron
Rapid Striatal D2-Receptor Signalingrecording from MSNs 7 days after animals had been injected
with AAV.
GIRK2 protein levels were initially quantified by western blot 7
and 24 days following AAV injection. GIRK2 expression
increased by 3-fold between the 7th and 24th day after AAV in-
jection (n = 3, p < 0.05, Student’s paired t test) (Figures 5A and
5B). At 7 days postinjection, GIRK2 expression was 3-fold
greater than control (3 ± 1 fold, n = 3, p < 0.05 versus control
hemisphere, Student’s paired t test), while at 24 days, GIRK2
levels were 10-fold greater than in the uninjected control hemi-
sphere (10 ± 1 fold, n = 3, p < 0.01 versus control hemisphere,
Student’s paired t test) (Figures 5A and 5B). To assess how dif-
ferences in GIRK expression may affect the D2-IPSC, whole-cell
voltage-clamp recordings were performed from GIRK2+ MSNs
in slices 7 days following injection of AAV (range: 5–9 days,
mean = 7). Due to reduced expression of GIRK, D2-IPSCs
were 6-fold smaller in amplitude than control IPSCs recorded
at least 21 days following injection (7 day postinjection: 18 ±
4 pA, n = 8; >21 days postinjection: 102 ± 5 pA, n = 130, p <
0.001, Student’s unpaired t test) (Figures 5C and 5D).
In brain slices taken from mice 7 days post-AAV injection,
dopamine dose response measurements were repeated in the
presence of 10 mM cocaine (Figures 5C and 5D). Dopamine con-
centration-response curves for both the inhibition of the IPSC
and the dopamine-induced outward current were constructed
(Figures 5E and 5F). The inhibition of the IPSC in slices taken
from animals 7 days postinjection had an IC50 of 7 mM (95% con-
fidence interval = 6 mM to 8 mM) (Figure 5E), which was not
different than the IC50 for the inhibition of the IPSC in slices taken
from animals greater than 21-days postinjection (IC50 = 9 mM,
95% confidence interval = 5 mM to 12 mM), as indicated by their
overlapping 95% confidence intervals. Likewise, there was no
difference in the EC50 of the dopamine-mediated standing out-ward current between MSNs following 7 or >21 days of GIRK2
expression (7-day expression: 10 mM, 95% confidence interval =
4 mM to 16 mM; >21-day expression: 16 mM, 95% confidence
interval = 7 mM to 24 mM). The Emax of D2-receptor activation,
however, as measured as the size of the outward current pro-
duced by 100 mM dopamine, was greater in mice with >21-day
expression (>21-day expression: 190 ± 36 pA, n = 7; 7-day
expression: 27 ± 6 pA, n = 11; p < 0.001, Student’s unpaired t
test) (Figure 5F). The results indicate that altering the size of
the GIRK effector pool changes the maximum current evoked
by dopamine but does not affect the potency of dopamine for
the D2-receptor. Thus, despite differences in GIRK expression,
there was no difference in the functional sensitivity of D2-recep-
tor-mediated currents.
Transporters Regulate the Extent of D2-Receptor
Activation during Repetitive Stimulation
The kinetics of D2-IPSCs indicated that a single stimulation likely
did not drive prolonged activation of D2-receptors. To examine
if repetitive stimulation of dopamine terminals would lead to an
increase in baseline D2-receptor activation, we repeatedly acti-
vated ChR2-expressing dopamine terminals using a 30 s train
of optogenetic stimuli (1 Hz, 2 ms pulse) in an attempt to
mimic tonic pacemaker firing of midbrain dopamine neurons.
Recording from GIRK2+ MSNs, light intensity was set such that
the first evoked IPSC was roughly 50% maximum amplitude
(0.4 mW). This intensity of optogenetic stimulation produced
a peak [DA]o of 191 ± 19 nM (n = 8) for the first pulse and a steady
state [DA]o (>7 pulses after the initial pulse; ‘‘plateau’’) of 61 ±
11 nM (n = 8), as measured by FSCV (Figure 6A). This level of
dopamine tone in the slice would be expected to activate D2-re-
ceptors in the high-affinity state (Richfield et al., 1989). Despite
the elevated background levels of dopamine in the extracellularNeuron 84, 164–176, October 1, 2014 ª2014 Elsevier Inc. 169
Figure 5. GIRK Overexpression Does Not Affect the Affinity of D2-
Receptors
(A) Representative western blot showing GIRK2 protein overexpression at 7
and 24 days following AAV injection. GAPDH is shown as a loading control.
(B) Quantification showing the fold-increase in GIRK2 expression at 7 and
24 days following AAV injection. Expression levels of GIRK2 were normalized
to GAPDH. Fold change was calculated with respect to GIRK2 levels in the
respective uninjected hemisphere. Numbers in bar graph represent number of
animal replicates.
(C) D2-IPSC recorded from GIRK2+ MSNs in brain slices from mice either
7 days (control, black; in 10 mM cocaine, orange) (range: 5 to 9) or >21 days (in
10 mM cocaine, purple) after AAV injection.
(D) Summary data showing the amplitude of the D2-IPSC in mice with 7-day
and >21-day expression of GIRK2. The increase in IPSC amplitude from day 7
to day 21 following injection reflects the increase in GIRK2 expression.
Numbers in bar graphs represent number of cells recorded.
(E) Concentration-response curve for the inhibition of the D2-IPSC by bath
application of dopamine (performed in 10 mM cocaine) in GIRK2-injected mice
with >21-day (purple) and 7-day (orange) expression. No change in the IC50 is
seen (>21-day: IC50 = 9 mM; 7-day: IC50 = 7 mM).
(F) Concentration-response curve for the outward current produced by bath
application of dopamine (performed in 10 mM cocaine) in GIRK2-injected mice
with >21-day (purple) and 7-day (orange) expression. There is an increase in
themaximum effect produced by 100 mMdopamine (>21-day: 190 ± 36 pA, n =
7; 7-day expression: 27 ± 6 pA, n = 11), but there is no change in the EC50 (24-
day: EC50 = 15 mM, n = 7; 7-day: EC50 = 10 mM, n = 11). Error bars indicate ±
SEM. * = p < 0.05, ** = p < 0.01, and *** = p < 0.001 by Student’s t test.
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170 Neuron 84, 164–176, October 1, 2014 ª2014 Elsevier Inc.space, each flash in the train reliably evoked an individual D2-
IPSC (Figure 6B). Following an initial decline in the amplitude,
IPSCs reached a stable amplitude of 24 ± 5 pA (n = 15). Each
D2-IPSC returned to a flat baseline before the next was initiated
(Figure 6B, insert). No change in the baseline holding current was
observed between each of the IPSCs in the train (1 ± 1 pA, n = 15,
p = 0.1, Student’s one-sample t test) (Figures 6B and 6G), sug-
gesting that the 60 nM background level of dopamine in the
slice that could be detected with FSCV (Figure 6A) did not lead
to the tonic activation of D2-receptors. As the rate of GIRK acti-
vation is determined by the concentration of dopamine at the D2-
receptor (Courtney and Ford, 2014; Ford et al., 2009), the fact
that the rise times (10%–90%) of IPSCs did not change over
the course of the 30 s train (n = 9, p = 0.1, Pearson’s correlation)
(Figure 6C) suggests that each was the result of a similar sharp
rise in a high concentration of dopamine.
Because DAT-mediated uptake determined the duration of
D2-IPSCs evoked by a single stimulation (Figure 3C), we next
sought to determine whether DATs limit persistent D2-receptor
activation during repeated synaptic events. Cocaine (3 mM)
increased the steady-state level of dopamine when measured
with FSCV (‘‘plateau’’ = 225 ± 51 nM; n = 7, p < 0.001 versus con-
trol, Student’s unpaired t test) (Figure 6A) and facilitated the
amplitude and duration of D2-IPSCs evoked during the train of
optogenetic stimulation (Figure 6D). The duration of each IPSC
was prolonged such that the next IPSC was initiated before the
preceding synaptic current returned to baseline. This led to a
change in the overall baseline between each oscillation (standing
outward current: 27 ± 5 pA, n = 13, p < 0.001 versus control, Stu-
dent’s unpaired t test) (Figure 6D), which increased the contribu-
tion of tonic signaling to the total amplitude of D2-receptor-medi-
ated standing outward current occurring during the train (57% ±
5%, p < 0.001, n = 13–15, Student’s unpaired t test) (Figure 6E).
Individual IPSCs could still be resolved superimposed on this
standing outward current (Figure 6D, insert).
Since dopamine neuron pacemaker firing in vivo typically oc-
curs in frequencies ranging from 3–8 Hz (Grace and Bunney,
1984a), we also increased the frequency of optogenetic stimu-
lation during the 30 s train. In the absence of cocaine,
increasing the frequency of stimulation of ChR2-expressing
dopamine terminals to 2 Hz still resulted in small, phasic D2-
IPSCs (Figure 6F) but also induced a shift in the baseline holding
current in between each oscillation (2 Hz optogenetic stimula-
tion: 16 ± 5 pA, n = 7, p < 0.05, Student’s one-sample t test)
(Figures 6F and 6G). Subsequent stimulation at higher fre-
quencies (5 Hz, Figure S3G) led to a summation of individual
phasic D2-IPSCs such that only a sustained standing outward
current could be observed (19 ± 6 pA, n = 11, p < 0.01, Stu-
dent’s one-sample t test) (Figures 6F and 6G). These results
indicate that at frequencies at least up to 2 Hz, D2-receptors
could encode the synaptic release of dopamine as individual
signaling events.
Tonic Extracellular Dopamine Does Not Occlude
the D2-IPSC
As bath application of high concentrations of dopamine were
required to drive large amplitude D2-receptor-mediated out-
ward currents (Figure 4D), it is likely that low concentrations
Figure 6. Transporters Limit Sustained Activation of D2-Receptors
(A) FSCV measurements of the [DA]o following repetitive optogenetic stimulation of striatal ChR2-expressing dopamine terminals. During 1 Hz optogenetic
stimulation (30 s, 2ms pulse), the [DA]o peaked and thenmaintained a plateau for the duration of the train. Right: summary of the [DA]o evoked following 1Hz (30 s,
2 ms pulse) stimulation under control conditions and in the presence of cocaine (3 mM). Numbers in bar graphs represent number of slices used to measure [DA]o.
Light intensity was set so as to produce 50% maximum amplitude D2-IPSCs (0.4 mW) in a separate set of slices expressing both GIRK2 and ChR2.
(B) Electrophysiological recording from a GIRK2+ MSN following similar optogenetic stimulation of striatal dopamine terminals expressing ChR2 (1 Hz, 30 s, 2 ms
pulse). At 1 Hz, stimulation evokes discrete oscillations in GIRK2+ MSNs with no change in baseline holding current. Trace is the average across nine GIRK2+
MSNs. Insert, expanded trace showing oscillations. Pulse width = 2 ms.
(C) Summary 10%–90% rise time of each IPSC in the train (n = 9, p = 0.1, Pearson’s correlation).
(D) In the presence of cocaine (3 mM), similar optogenetic stimulation of ChR2-expressing dopamine terminals induces an increase in the standing outward
current in GIRK2+ MSNs with superimposed phasic oscillations. Trace is the average across seven GIRK2+ MSNs.
(E) Summary data showing quantification of the oscillations (magenta) and shift in the apparent baseline (green) as components of the total outward current
measured under control conditions (n = 15) and in 3 mMcocaine (n = 13), as illustrated in (B) and (D). A significant tonic component of the current is only seen when
reuptake is blocked with cocaine (p < 0.001).
(F) Increasing the frequency of optogenetic stimulation decreases the ratio of the phasic D2-IPSC to tonic standing outward current during the duration of the flash
train. Top: 2 Hz stimulation; bottom: 5 Hz stimulation.
(G) Summary of the amplitude of the baseline current resulting from different frequencies of optogenetic stimulation. Numbers in bar graphs represent number of
cells recorded. Error bars indicate ± SEM. * = p < 0.05, ** = p < 0.01, and *** = p < 0.001 by Student’s t test.
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MSNs. To examine whether D2-receptors could differentially
respond to a strong stimulation in the presence of tonic back-
ground activity, we again mimicked the pacemaker firing of
dopamine neurons by repetitively stimulating ChR2-expressing
dopamine terminals for several minutes (1 Hz, 2 ms pulse, light
intensity set to 50% maximum D2-IPSC amplitude). As
above, repetitive optogenetic stimulation (1 Hz) evoked a series
of D2-IPSCs that were entrained to the flashes of light for the
duration of the experiment (Figure 7A). Following 2 min of opto-
genetic stimulation, a strong electrical stimulation was given to
synchronously activate the majority of dopamine synaptic in-
puts to the MSN being recorded (stimulation intensity set to
95% maximum). Despite background dopamine terminal
stimulation for 2 min, the amplitude of the electrically evoked
D2-IPSC was similar to control D2-IPSCs evoked prior tooptogenetic stimulation (pre: 92 ± 9 pA; during optogenetic
stimulation: 87 ± 10 pA; n = 7, p = 0.4, Student’s paired
t test) (Figure 7B).
We repeated the same experiment across multiple stimulation
frequencies to account for different dopamine neuron pace-
making frequencies (Grace and Bunney, 1984a). At 2 Hz and
5 Hz there was still no change in the amplitude of the electrically
evoked IPSC (2 Hz optogenetic stimulation: 94% ± 5% remain-
ing after optogenetic stimulation, n = 5, p = 0.4; 5 Hz optogenetic
stimulation: 97% ± 5% remaining after optogenetic stimulation,
n = 7, p = 0.7, Student’s paired t test) (Figures 7C and 7D).
Even at the high frequency of 24 Hz, no occlusion of the IPSC
was observed (Figure 7D). Instead, a small facilitation of the
IPSC was seen (121% ± 9% increase in IPSC amplitude, n = 6,
p = 0.05, Student’s paired t test). These results show that, in
the brain slice, phasic D2-IPSCs could still be evoked in theNeuron 84, 164–176, October 1, 2014 ª2014 Elsevier Inc. 171
Figure 7. D2-Receptors onMSNs Respond to Both Tonic and Phasic
Dopamine Release
(A) To mimic tonic firing of dopamine neurons in striatal slices, repetitive op-
togenetic stimulation (Flash) (2 min, 1 Hz, 2ms pulse width, light intensity set to
evoke D2-IPSC 50% maximum amplitude, 0.4 mW) was used while
recording from GIRK2+ MSNs. Electrical stimulation (Stim) (95% maximum
amplitude) was used to evoke a control D2-IPSC and a second D2-IPSC 2 min
later during the sustained train of optogenetic stimulation.
(B) Summary of the amplitude of electrically evoked control D2-IPSCs and
IPSCs following 2 min of 1 Hz optogenetic stimulation. Each circle represents
an individual cell (n = 7). There was no difference in the amplitude of D2-IPSCs
pre- and post-optogenetic stimulation.
(C) Repeated experiment as in (A) but using 5 Hz optogenetic stimulation (n =
7). Inset: summary of the amplitude of electrically evoked IPSCs.
(D) Summary of the ratio of D2-IPSCs evoked by electrical stimulation before
and after 2 min of optogenetic stimulation of dopamine terminals at 1, 2, 5, and
24 Hz. Only 24 Hz optogenetic stimulation facilitated the amplitude of D2-
IPSCs. Error bars indicate ± SEM. ns = p > 0.05 and * = p = 0.05 by Student’s
paired t test. # = p < 0.05 by one-way ANOVA, Tukey-Kramer test.
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stimulation of dopamine terminals.
DISCUSSION
To date, the dynamics of striatal dopamine release have been
widely studied using techniques that measure the extracellular
concentration of dopamine (Chergui et al., 1994; Garris et al.,
1994; Howe et al., 2013; Phillips et al., 2003). However, it has re-
mained unclear how release events mediate postsynaptic dopa-
mine receptor activation. In the present study, we introduced a
potassium conductance to provide a new sensor of D2-receptor
activation in MSNs. We found that IPSCs mediated by D2-re-
ceptor activation of GIRK channels occurred in under a second.
These results indicate that D2-receptors are capable of encod-
ing synaptic dopamine transients as distinct temporal events.
We found that following a single stimulation, the release of
dopamine led to only a brief activation of D2-receptors. Activation
of the GIRK conductance occurred with a rise time of 111 ms
(10%–90%) and lasted550ms (20%width). As the extracellular172 Neuron 84, 164–176, October 1, 2014 ª2014 Elsevier Inc.dopamine transient that could be detected in the extracellular
space occurred prior to the onset of the D2-IPSC, the time course
of activation of the D2-IPSC was likely limited by the rate of acti-
vation of D2-receptor/G protein/GIRK channels rather than the
diffusion of dopamine from the release site. Due to the large size
of the carbon fiber, FSCV samples bulk extracellular DA resulting
from spillover from multiple release sites (Kawagoe et al., 1992).
We found that the concentrations of dopamine required to drive
GIRK currents and inhibit D2-IPSCs were higher than those de-
tected by the carbon fiber following evoked release. As the con-
centration of DA decreases sharply as a function of distance
away from the site of release (Cragg and Rice, 2004), the peak
concentration of dopamine measured by the carbon fiber in the
extracellular space is likely lower than the synaptic concentration
present at D2-receptors mediating the IPSC. In isolated systems,
only brief applications of saturating concentrations of agonists
driveGPCR-coupledGIRKchannel activationwith similar kinetics
to that seen during the D2-IPSC (Courtney and Ford, 2014; Ford
et al., 2009; Sodickson and Bean, 1996). The activation of synap-
tic D2-receptors in MSNs underlying the IPSC therefore likely re-
sulted from a sharp rise in the local concentration of dopamine.
At somatodendritic sites in the midbrain, the release of dopa-
mine on to D2-receptors also drives a GIRK channel-mediated
IPSC (Beckstead et al., 2004). Despite differences in the anatom-
ical location andmechanisms regulating the release of dopamine
at axon terminals in the striatum and somatodendritic terminals
in the midbrain (Schmitz et al., 2003), both IPSCs exhibited a
remarkable similarity in their duration, kinetics, and dependence
on uptake transporters for terminating their signaling (Beckstead
et al., 2004; Ford et al., 2010). As individual vesicular release of
dopamine is sufficient to drive the spontaneous activation of
D2-receptors at somatodendritic synapses in the midbrain
(Gantz et al., 2013), metabotropic transmission through the D2-
receptor in multiple brain regions may involve a more localized
form of point-to-point signaling similar to that observed at
ligand-gated ion channel synapses.
Like other GPCRs, dopamine receptors can exist in multiple
affinity states (Richfield et al., 1989; Sibley et al., 1982). Accord-
ing to the ternary complex model (De Lean et al., 1980), the high-
affinity state reflects the stabilized complex under guanine
nucleotide-depleted conditions (Skinbjerg et al., 2012). In the
presence of sodium and GTP, G proteins uncouple from the re-
ceptor, and the low-affinity state is favored (Kenakin, 1996, 2013;
Sibley et al., 1983). Since many of the biochemical binding as-
says that have classified dopamine D2-receptor affinity were
done in membrane preparations in the absence of GTP, these
measurements of affinity may differ from the functional state of
the receptor in intact neurons (Sibley et al., 1983; Skinbjerg
et al., 2012; van Wieringen et al., 2013). Both the high- and
low-affinity states of the D2-receptor may be present in a given
cell, but due to the high intracellular concentration of GTP, func-
tionally coupled dopamine receptors in the low-affinity state
likely predominate (Castro et al., 2013; Ford et al., 2009; Schof-
felmeer et al., 1994; Sibley et al., 1983).
In native GPCR systems, receptors, G proteins, and effectors
have been estimated to exist in a ratio of 1:200:3 (Post et al.,
1995). Due to abundance of G proteins, the pool of available
effectors, not the receptors, often limits the maximal response
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tems have shown that increases in the relative concentration of
GPCRs lead to a shift in the concentration-response curve (Ke-
nakin, 2013), while increased expression of effectors increases
the efficacy without altering the functional affinity of agonists
(Ostrom et al., 2001). In MSNs, we found that the observed low
affinity of dopamine for the D2-receptor was not dependent on
the extent of GIRK expression. Examining the expression of
GIRK over a 14-day period, we found that while there was a
3-fold increase in the amount of GIRK expression that corre-
sponded to a 6-fold increase in the maximal effect of D2-recep-
tor activation, there was no associated change in the EC50. Thus,
the low-affinity state of the D2-receptor may play a larger func-
tional role in striatal signaling in MSNs than previously thought.
As stimulatory D1-receptors are expressed on direct pathway
MSNs and inhibitory D2-receptors are expressed on indirect
pathwayMSNs, dopamine is thought tomaintain the balance be-
tween direct and indirect striatal activity in order to maintain
appropriate output from the striatum (Albin et al., 1989; DeLong,
1990; Kravitz et al., 2010). Phasic dopamine events are proposed
to signal the value of learned reward-predictive cues that drive
motivated behavior (Schultz, 2007a). Based on studies of dopa-
mine receptor affinity, it has been assumed that these dopamine
transients primarily activate low-affinity D1-receptors on the
direct pathway. Our finding that striatal D2-receptors can
respond to subsecond dopamine events suggests that these
goal-directed actions may be driven, at least partially, by D2-re-
ceptor signaling in indirect pathway MSNs. Since dopamine
terminals in the striatum exhibit dense axonal arborizations (Ar-
buthnott and Wickens, 2007; Matsuda et al., 2009), the firing of
a single dopamine cell has been thought to provide dopamine
tone to a large area encompassing many synapses. However,
as we found that at low frequencies stimulation of dopamine ter-
minals evoked a series of IPSCs, despite the extracellular basal
tone of60 nM, local mechanismsmay tightly limit the sphere of
influence over which dopamine signals at individual release
sites. Over a range of stimulation frequencies, we found that
robust D2-IPSCs could still be evoked superimposed on a dopa-
mine-mediated standing outward GIRK current when driven by a
strong stimulus. Thus, despite the presence of baseline D2-re-
ceptor activation, phasic increases in the release of dopamine
could still be differentially encoded in MSNs by D2-receptors.
D2-receptors are central to the etiology of many psychiatric
diseases, including schizophrenia (Howes and Kapur, 2009;
Seeman et al., 2005), and current therapeutic approaches in
the treatment of these diseases rely on global antagonism of
this class of dopamine receptor. The unexpected finding that
low-affinity D2-receptors are activated by phasic dopamine
transients raises the possibility for new pharmacological inter-
ventions that may specifically target the rapid interactions of
dopamine with the D2-receptor.EXPERIMENTAL PROCEDURES
Stereotaxic Injection
All animal procedures were performed in accordance with the guidelines of the
Institutional Animal Care and Use Committee at Case Western Reserve Univer-
sity. Wild-type C57BL6 or TH::internal ribosomal entry site (IRES)-Cre heterozy-gote transgenicmice were injected at age postnatal day 21. The coordinates for
injection were (with respect to bregma) striatum: AP +1.2 mm, ML +1.8 mm, DV
3.35 mm; and substantia nigra pars compacta (SNc): AP 2.3 mm,
ML+0.45mm,DV4.7mm.Viruswas injected via apulledpipetteusingaNano-
ject II (Drummond Scientific). For striatal injections, a total volume of 300 nl of
AAV2/9.hSynapsin.tdTomato.T2A.mGIRK2-1-A22A.WPRE (Vollum Viral Core,
Oregon Health & Science University) was injected. In a few cases as noted (Fig-
ure S1), AAV2/9.hSynapsin.tdTomato.T2A.mGIRK2-1-A22A.WPRE was mixed
with AAV2/9.hSynapsin.eGFP.T2A.ratGIRK1-A32A.WPRE (Vollum Viral Core,
Oregon Health & Science University). For SNc injections, 500 nl of AAV5.EF1a.
DIO.hChR2(H134R)-EYFP.WPRE.hGH (University of Pennsylvania Viral Core)
or AAV9.CAG.hChR2(H134R).mCherry.WPRE.SV40 (University of Pennsylvania
Viral Core) was injected into the SNc of TH-Cre transgenic or wild-type C57BL6
mice, respectively. No difference was observed in the kinetics of light-evoked
D2-IPSCs between the two different ChR2 AAVs (time to peak: n = 16 to 17,
p = 0.2). Animals recovered for 3 to 4 weeks to allow for expression.
Immunohistochemistry
AAV2/9.hSynapsin.tdTomato.T2A.mGIRK2-1-A22A.WPRE-injectedmicewere
deeply anesthetized with an intraperitoneal injection of avertin (250 mg/kg).
Mice were transcardially perfused with ice-cold PBS containing (in mM) 137
NaCl, 1.5 KH2PO4, 8 NaH2PO4, and 2.7 KCl (pH = 7.4), followed by 4%parafor-
maldehyde in PBS. The brains were fixed overnight in 4% paraformaldehyde.
Fixed brainswere sectioned coronally in 25-mmsections. Free-floating sections
were permeabilized with 0.2% Triton X-100 in PBS (PBS-T) and blocked in 5%
normal goat serum in PBS-T for 1 hr at room temperature. Slices were washed
and incubated with 1:500 polyclonal rabbit anti-Kir3.2 antibodies (Alomone) in
PBS overnight at 4C. Sections were incubated with 1:500 Alexa 647-conju-
gated goat-anti-rabbit IgG (Invitrogen) in PBS for 2 hr at room temperature.
Slices were mounted onto microscope slides (Fisher Scientific). Fluorescent
confocal images were obtained using a Zeiss LSM 510 META laser scanning
confocal microscope (Carl Zeiss) with a 403 Plan-Neofluar, NA 1.3, oil-immer-
sion lens. All images were processed using ImageJ.
Western Blots
The striatum was dissected from control and GIRK2-injected hemispheres of
mice 7 days and 24 days following AAV injection. Tissue was homogenized
in tissue homogenization buffer (250 mM sucrose, 20 mM Tris-HCl [pH 7.4],
1 mM EDTA, and 1 mM EGTA) containing Protease Inhibitor Cocktail (Sigma)
and was sonicated. Protein concentrations were quantified by Pierce BCA
(Thermo Scientific). Equivalent amounts of protein were loaded into a 10%
SDS gel and resolved by SDS-PAGE. Protein was transferred to a polyvinyli-
dene fluoride membrane, blocked with 5% milk in TBS-T (0.1% Tween), and
probedwith anti-GIRK2 (Alomone) or anti-GAPDH (Santa Cruz Biotechnology).
Blots were probed with appropriate secondary antibody conjugated to HRP
(GE Healthcare). Proteins were visualized with enhanced chemiluminescence
(Millipore). Densitometry was performed with ImageJ, and GIRK2 protein
levels were normalized to GAPDH.
Slice Preparation
Coronal slices (240 mm) containing the striatum were made in ice-cold physi-
ological saline solution containing (in mM) 75 NaCl, 2.5 KCl, 6 MgCl2, 0.1
CaCl2, 1.2 NaH2PO4, 25 NaHCO3, 2.5 D-glucose, and 50 sucrose. Slices
were incubated at 35C for at least 45 min in ACSF containing (in mM) 126
NaCl, 2.5 KCl, 1.2 MgCl2, 2.5 CaCl2, 1.2 NaHPO4, 21.4 NaHCO3, 11.1
D-glucose, and 10 mM MK-801 while being bubbled with 95% O2 and 5%
CO2. Following incubation, slices were placed in a recording chamber and
were constantly perfusedwith ACSF (34C± 2C) at 2ml/min. ACSF contained
100 mMpicrotoxin, 10 mMDNQX, 300 nMCGP55845, 200 nM scopolamine hy-
drobromide, and 1 mMSCH 23390 hydrochloride to isolate D2-receptor-medi-
ated currents. MSNs were visualized with a BXWI51 microscope (Olympus)
with infrared gradient contrast optics. tdTomato was visualized by fluores-
cence using an LED (Thorlabs).
Electrophysiology
Whole-cell voltage clamp recordings were made from fluorescent (tdTomato+,
GIRK2+) MSNs using an Axopatch 200B amplifier (Molecular Devices) andNeuron 84, 164–176, October 1, 2014 ª2014 Elsevier Inc. 173
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Patch pipettes (1.5–2.0 MU) (World Precision Instruments) contained 115 mM
K-methylsulphate, 20 mM NaCl, 1.5 mM MgCl2, 10 mM HEPES(K), 10 mM
BAPTA-tetrapotassium, 1 mg/ml ATP, 0.1 mg/ml GTP, and 1.5 mg/ml phos-
phocreatine (pH 7.4, 275 mOsm). GIRK2+ MSNs were held at 60 mV. No
series resistance compensation was used, and cells were discarded if the ac-
cess resistance rose above 15 MU.
Electrical stimulation was used to evoke dopamine release using a monop-
olar ACSF-filled extracellular glass stimulating electrode. A single stimulation
(0.7 ms, 20–50 mA) was used to evoke release from dopamine terminals in
the striatum. Light-evoked dopamine release was elicited by stimulating
ChR2 with widefield 488 nm blue light (pulse width = 2 ms) through the objec-
tive via a white light LED (Thorlabs) filtered with a FITC bandpass filter set (460–
495 nm; Chroma) (0.2–1.0 mW/mm2). Drugs were applied by bath perfusion.
Quinpirole was applied either through a puffing pipette containing quinpirole
(100 mM) with a Picospritzer II (General Valve Corporation) or by bath applica-
tion. Dopamine was bath applied or iontophoresed via a thin-walled iontopho-
retic glass electrode that was loaded with 1 M dopamine and placed 10 mm
from the soma of the cell being recorded. Dopamine was ejected as a cation
(160 nA) for 1 s for maximum dopamine currents or in 20–50 ms pulses for sta-
ble iontophoretic currents (1 pulse/min). Leakage of dopamine was prevented
with a retention current of 3–20 nA.
FSCV
Electrochemical recordings were made using carbon fiber electrodes (34-700,
Goodfellow) encased within a glass pipette. Electrodes had an exposed diam-
eter of 7 mM and length of 50–100 mm. The carbon fiber tip was soaked in
activated carbon-purified isopropanol for 20–30 min prior to use. The tip of
the fiber was placed in striatum 30–70 mm below the surface of the slice.
The fiber was held at 0.4 V, and triangular waveforms (0.4 to 1.3 V versus
Ag/AgCl at 400 V/S) were applied at 10 Hz. Background subtracted cyclic vol-
tammogram currents were obtained by subtracting the average of 10 voltam-
mograms obtained prior to stimulation from each voltammogram obtained
after stimulation. The time course of dopamine was determined by plotting
their peak oxidation potentials versus time. After experimentation, each elec-
trode was calibrated against known concentrations of dopamine. In all cases,
the stimulation intensity and duration used to evoke dopamine release was the
same as in electrophysiological experiments.
Materials
Picrotoxin, DNQX, and MK-801 were obtained from Ascent Scientific. CGP
55845, scopolamine hydrobromide, SCH 23390, S-()-sulpiride, and tertia-
pin-Q were from Tocris Bioscience. K-methylsulphate was from Acros
Organic, and BAPTA was from Invitrogen. Cocaine hydrochloride was ob-
tained from the National Institute of Drug Abuse. All other chemicals were
from Sigma-Aldrich.
Statistics and Analysis
Data are shown as mean ± SEM. Statistical significance was determined using
a one-way ANOVA, Pearson’s correlation, or a Student’s paired or unpaired t
test, as appropriate (InStat 3.0, Graphpad). Statistical significancewas defined
as p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***). Activation kinetics of the D2-
IPSCwas analyzed by subtracting traces recorded in the presence of sulpiride
from traces containing D2-IPSCs to blank the stimulation artifact.
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